# Clinical Study on Intraluminal Injection of FOLactis

> **NCT06512896** · NA · RECRUITING · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 40 (estimated)

## Conditions studied

- Solid Tumor
- Immune Response
- Pleural Effusion, Malignant
- Peritoneal Effusion

## Interventions

- **OTHER:** FOLactis

## Key facts

- **NCT ID:** NCT06512896
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-01
- **Primary completion:** 2025-03-30
- **Final completion:** 2026-05-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06512896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06512896, "Clinical Study on Intraluminal Injection of FOLactis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06512896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*